About FDA

In Vitro Diagnostics

FY 2009 MDUFA Performance Report Table of Contents

Under the HHS Commitment Letter, FDA is studying and pursuing a variety of approaches to clarify its regulatory requirements and reduce regulatory burdens. As part of this effort, FDA published three new guidance documents specifically called for in the HHS Commitment Letter:

Next page: Appendix A: September 27, 2007, Commitment Letter from HHS Secretary to Congress

Page Last Updated: 09/09/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English